Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis
about
Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on PhysiopathologyClinical Relevance of Biomarkers of Oxidative StressAsymmetric dimethylarginine as a mediator of vascular dysfunction in cirrhosisAsymmetric dimethyarginine as marker and mediator in ischemic strokeAsymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tablesAsymmetric Dimethylarginine and Its Relation As a Biomarker in Nephrologic DiseasesEndothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endotheliumInvolvement of accumulated endogenous NOS inhibitors and decreased NOS activity in the impaired neurogenic relaxation of the rabbit proximal urethra with ischaemiaDimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginineCurrent concepts in the diagnosis and classification of renal dysfunction in cirrhosis.Retinal metabolic events in preconditioning light stress as revealed by wide-spectrum targeted metabolomics.Mechanisms of nitric oxide synthase uncoupling in endotoxin-induced acute lung injury: role of asymmetric dimethylarginine.Efficacy of different nitric oxide-based strategies in preventing experimental cerebral malaria by Plasmodium berghei ANKA.Effects of angiotensin type 1 receptor blockade on arginine and ADMA synthesis and metabolic pathways in fawn-hooded hypertensive rats.Arginine supplementation for improving maternal and neonatal outcomes in hypertensive disorder of pregnancy: a systematic review.The hypothalamus and hypertension.Plasma levels of asymmetric dimethylarginine in patients with biopsy-proven nonalcoholic fatty liver disease.Amino acids, arginase and nitric oxide in vascular health.Impact of ADMA (asymmetric dimethylarginine) on physiology with respect to diabetes mellitus and respiratory system BEAS-2B cells (human bronchial epithelial cells).Symmetric dimethylarginine as predictor of graft loss and all-cause mortality in renal transplant recipientsAcute lung injury-induced collagen deposition is associated with elevated asymmetric dimethylarginine and arginase activity.Vascular Nitric Oxide: Formation and Function.Endothelial nitric oxide synthase polymorphisms and hypertension.Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia.Impaired systemic tetrahydrobiopterin bioavailability and increased oxidized biopterins in pediatric falciparum malaria: association with disease severity.Metabolic determinants of white matter hyperintensity burden in patients with ischemic stroke.Asymmetric dimethylarginine and whole blood viscosity in renal failure.Cardiovascular effects of frequent intensive hemodialysis.Asymmetrical dimethylarginine and severity of erectile dysfunction and their impact on cardiovascular events in patients with acute coronary syndromePharmacological effects of xanthones as cardiovascular protective agents.Nitric oxide synthase, ADMA, SDMA, and nitric oxide activity in the paraventricular nucleus throughout the etiology of renal wrap hypertension.Bioanalytical profile of the L-arginine/nitric oxide pathway and its evaluation by capillary electrophoresis.Effect of vitamin D on aortic remodeling in streptozotocin-induced diabetes.Pharmacokinetics and Tolerability of Intravenous Sildenafil in Two Subjects with Child-Turcotte-Pugh Class C Cirrhosis and Renal Dysfunction.Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor beta 1 null mouseγ-tocopherol nebulization decreases oxidative stress, arginase activity, and collagen deposition after burn and smoke inhalation in the ovine model.How to control NO production in cells: N(omega),N(omega)-dimethyl-L-arginine dimethylaminohydrolase as a novel drug target.Pulmonary hypertension associated with advanced systolic heart failure: dysregulated arginine metabolism and importance of compensatory dimethylarginine dimethylaminohydrolase-1.Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review.Combined Intraperitoneal and Intrathecal Etanercept Reduce Increased Brain Tumor Necrosis Factor-Alpha and Asymmetric Dimethylarginine Levels and Rescues Spatial Deficits in Young Rats after Bile Duct Ligation.
P2860
Q26744760-51F2B64A-6830-4900-B555-0513F90B50C7Q26785512-C4A9630F-AE74-4296-A59D-24FA41CBA0E9Q26795604-8701AAED-65F1-4566-A2CF-8C2A7811254CQ26864318-C8FA0F51-2C56-4CC3-88D5-4A80D2D2DCDAQ26865426-810E6BEC-874B-4F17-ABB7-4A17A90349FDQ28078222-88931CDB-FD44-403F-8948-4D7CF257763DQ28219326-9BC5261D-1737-4F00-977E-9A2CBE823102Q28363811-EB07E88B-9A4A-43D2-8E3C-D139ABC4BADDQ28506246-4ED31A78-AA89-4DF1-A33F-6966F5369A57Q33811643-9483F14A-0401-4575-92C3-B6C38DAC6B64Q33841046-10B20444-CB9D-48BA-A50B-5E9D10D5B6CCQ33889586-5FE6A43D-A7BD-4FB4-899F-AE349FF32887Q34163836-39ACFEC3-1E85-4DD0-8C99-8E013789BFD5Q34308232-7261A96B-9AB1-46A4-8FC5-03B3DDD3BA4CQ34329468-70CFC1C5-1CAC-484F-88A2-6BEE653156B8Q34388100-499D06C7-324C-4600-B138-1D501EB516F1Q34448584-E2C53EE2-AD3A-49D4-891F-CD665A5A068EQ34489450-56B183EC-2A8E-450B-9BF6-7051F0CA3EBAQ34528405-82E4A792-BFDE-4542-93CA-4BFB27F0BD9CQ34556614-277C0A95-9426-4D08-87ED-767F59435A3BQ34587795-1790FE3E-751B-4460-9F62-3960F7AB1636Q34973956-3F0D55D8-FC3D-4C1E-9C81-A1829DDD53C1Q35046483-7794E189-7892-4C50-B000-5FE71899AC89Q35055199-DDCAD70F-A73C-4C35-8342-F050B9C1B7B2Q35170667-EC52A9FF-3641-4C4E-944A-CD71894C76CDQ35418370-475A11AB-EF79-4C9B-A451-8E94FF096DCBQ35533251-96206485-40D0-402F-B8A8-154D473B27E1Q35714230-B61A715C-692E-4874-B22A-C026ABFA8B10Q35762008-450B52C9-D4F7-4831-AD9E-CF9FCA119F79Q35793189-73DF6DC1-B86B-4719-949E-AC53BE22CA34Q36042613-DBE17465-9370-4017-9021-14B89E347DEDQ36088976-8686CF9E-EE7C-4C58-8CEF-522912EA09F8Q36100744-12BBA2E5-D72C-4F2C-AD98-2DACECED2B74Q36217672-67E729A1-4B22-4442-B9EC-8A869113B417Q36366625-F43643D9-490D-4F88-AE6C-D0317D9C7587Q36417822-19DD7430-DC1D-44DE-A976-6FC97525B949Q36471209-C62324A6-E0E3-4506-B967-163B39BB1318Q36590608-D7DFD8B5-071B-4669-BDB5-8355EED2BF1AQ36612606-DD819746-0E42-4B30-B526-1673BB4D21AEQ37029990-A7C2D14C-3580-4908-BC81-2F973C64B022
P2860
Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis
description
1992 nî lūn-bûn
@nan
1992 թուականին հրատարակուած գիտական յօդուած
@hyw
1992 թվականին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis
@ast
Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis
@en
Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis
@nl
type
label
Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis
@ast
Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis
@en
Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis
@nl
prefLabel
Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis
@ast
Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis
@en
Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis
@nl
P2093
P3181
P1476
Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis
@en
P2093
P3181
P356
10.1097/00005344-199204002-00018
P407
P478
20 Suppl 12
P577
1992-01-01T00:00:00Z